Category: Regulatory/FDA

doctor story

08/26/2019

OPDP to Study How Source, Graphics and Time Affect Physician Perceptions of Info

CHC_FDA-Regulatory Images1

08/05/2019

Latest OPDP Enforcement Letters: Don’t Omit or Distract from Risk Information

News Aikin

07/22/2019

OPDP’s Aikin Highlights Role of Social Science Research in FDA Promotional Policymaking

Myers News

07/01/2019

FDA’s Second Half: Org Changes, Updating Trial Design and Promotional Regulation, 2020 Budget

CHC_FDA-Regulatory Images1

06/19/2019

OPDP Untitled Letter Cites False, Misleading Claims about Efficacy, Risk Presentation for Obesity Drug

Myers News

06/03/2019

FDA After Gottlieb: Will Sharpless Stay the Course?

News Sharpless (1)

05/06/2019

FDA Leaders Highlight Issues, Opportunities of Real-world Data Post-marketing

CHC_FDA-Regulatory Images1

04/30/2019

OPDP Issues Enforcement Letter for Investigational Drug Promotion

CHC_FDA-Regulatory Images1

03/28/2019

FDA Applies Increased Scrutiny to Nutritional Supplements Claiming Pain Relief